Eight studies researched the association between LAPTM4B polymorphism and tumor TNM stage, and only three found that LAPTM4B polymorphism was significantly associated with cancer histopathologic differentiation and TNM stage, while the present meta-analysis indicated that LAPTM4B polymorphism was associated with histopathologic differentiation and TNM stage. This evidence concerns the gene LAPTM4B and neoplasm.